DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR NEDAPLATIN
» See Plans and Pricing
Clinical Trials for Nedaplatin
| Trial ID | Title | Status | Sponsor | Phase | Summary |
|---|---|---|---|---|---|
| NCT00197444 | Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer | Completed | Hamamatsu University | Phase 2 | The purpose of this study is to clarify efficacy and toxicity of daily low-dose Nedaplatin (CDGP) and continuous infusion of 5-FU combined with radiation in patients with esophageal squamous cell carcinoma. |
| NCT01040312 | An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors | Unknown status | Daiichi Sankyo Co., Ltd. | N/A | The purpose of this study is to examine the correlation between UGT1A1 genotypes and the safety of CPT-11 plus platinum analogues (cisplatin, carboplatin and nedaplatin) regimens for patients with lung cancer, cervical cancer, ovarian cancer and gastric cancer. |
| NCT01137123 | Improve the Treatment of Thoracic Esophageal Cancer | Recruiting | Sun Yat-sen University | Phase 3 | The purpose of this study is 1. To compare the effects of the two types of thoracic esophageal cancer lymphadenectomy on the staging and prognosis of resectable esophageal cancer, which defined by the International Association of esophageal disease(ISDE) - standard mediastinal lymphadenectomy,total mediastinal lymphadenectomy and three field lymphadenectomy,and to find out reasonable range of lymphadenectomy. 2. To compare the effects of Chemotherapy Group (Docetaxel + Nedaplatin) with Control Group on the prognosis of resectable thoracic esophageal cancer,and to explore the indications of adjuvant chemotherapy. |
| NCT01175460 | S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer | Completed | Zhejiang Cancer Hospital | Phase 1 | Patients with advanced esophageal cancer will receive thoracic radiation therapy 60Gy over 30 fractions,and concurrent with s-1 and nedaplatin. |
| NCT01201044 | Study to Investigate Bronchial Arterrial Infusing (BAI) Plus Three-dimensional Conformal Radiotherapy (3DCRT) in Local Advanced Non-small Cell Lung Cancer (NSCLC) | Unknown status | Third Military Medical University | N/A | The purpose of this study is to investigate the efficacy of BAI Plus 3DCRT in local advanced NSCLC. |
| NCT01265147 | Intensity-modulated Radiation Therapy Combined With Cisplatin or Nedaplatin Chemotherapy in Nasopharyngeal Carcinoma | Not yet recruiting | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Phase 2 | This phase II trial is studying cisplatin or nedaplatin combine with IMRT to evaluate which one is better efficacy and security in nasopharyngeal carcinoma. |
| NCT01479504 | A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | Recruiting | 303rd Hospital of the People's Liberation Army | Phase 3 | This study is a multicenter trial.The primary objective is to estimate short-term efficacy and acute toxicities of nedaplatin to the combination of docetaxel in neoadjuvant chemotherapy followed by nedaplatin in concurrent chemoradiotherapy, compared to cisplatin to the combination of docetaxel in neoadjuvant chemotherapy followed by cisplatin in concurrent chemoradiotherapy for patients with locoregionally advanced nasopharyngeal carcinoma. Secondary objectives are to evaluate the overall survival, the distant metastases free survival, and disease free survival of patients with locoregionally advanced nasopharyngeal carcinoma treated with these regimens.Furthermore,analyze the cost-effectiveness of the regimens. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Nedaplatin
Condition Name
Condition MeSH
Clinical Trial Locations for Nedaplatin
Clinical Trial Progress for Nedaplatin
Clinical Trial Phase
Clinical Trial Sponsors for Nedaplatin
Sponsor Name
